Contact Info

Email: [email protected]

Dr. Sai Vivek Velukuru

  • Degrees:

  • Experience:

  • Courses:

  • MBBS • MD • DM, MRCP (SCE UK), MSc Precision Cancer Medicine (in progress) University of Oxford, UK

  • 10+ Years, Medical Oncology

  • Gynecological Oncology




Introduction and Speciality

Dr. Sai Vivek Velukuru is a Consultant Medical Oncologist at Aster Hospitals, Bangalore, with over 10 years of experience in the field of oncology. He is currently pursuing an MSc in Precision Cancer Medicine at the University of Oxford, UK, and holds the prestigious MRCP with Specialty Certificate Examination (SCE) in Medical Oncology from the United Kingdom.

He specialises in precision cancer medicine and gynaecologic oncology, with a particular focus on molecular tumour profiling, liquid biopsy, and biomarker-driven treatment strategies. He has been instrumental in establishing the Molecular Tumour Board at Aster Hospitals, Bangalore – one of the pioneering initiatives integrating comprehensive genomic profiling into routine clinical practice in India.

Dr. Sai Vivek is certified by the International Society of Liquid Biopsy (ISLB) and holds active memberships in ISMPO, ASCO, and ESMO. His research portfolio includes peer-reviewed publications in high-impact journals such as ESMO Open and the International Journal of Translational Medicine, with a strong focus on gynaecologic and gastrointestinal oncology in the South Asian population.


Qualifications:

  • MBBS – Rajiv Gandhi University of Health Sciences, Bengaluru (2006–2012)

  • MD (Doctor of Medicine) – JSS University, Mysore (2012–2015)

  • DM – Fellowship in Medical and Haemato-Oncology, Rajiv Gandhi University of Health Sciences, Bengaluru (2016–2019)

  • MRCP with Specialty Certificate Examination (SCE) in Medical Oncology – Royal College of Physicians, United Kingdom

  • MSc in Precision Cancer Medicine – University of Oxford, UK (2024–Present)

  • Certified by the International Society of Liquid Biopsy (ISLB)


Experience:

  • Senior Consultant – Medical Oncology | Aster Hospitals, Bengaluru (February 2023–Present). OPD consultations and daycare chemotherapy administration. Established and leads the Molecular Tumour Board, integrating next-generation sequencing and comprehensive genomic profiling into clinical oncology practice.

  • Junior Consultant – Medical Oncology | Sri Shankara Cancer Hospital and Research Centre, Bengaluru (August 2019–February 2023). OPD consultations, inpatient and daycare chemotherapy administration, teaching modules for residents, and research activities.

  • Resident – Medical Oncology | Vydehi Institute of Medical Sciences and Research Centre, Bengaluru (June 2016–July 2019). OPD and ward patient management. Performed over 1,000 bone marrow aspirations and 500+ intrathecal administrations.



Publications and Work (Selected):

  • HER-2 neu overexpression in epithelial ovarian cancers: A multicentric retrospective study to ascertain the prevalence of a potential therapeutic target. ESMO Open, Volume 10, 105223, June 2025.

  • Clinical Applications of Tissue-Free Molecular Residual Disease (MRD) in Colorectal Cancer – Real-World Utilisation and Case Series in Asian and Middle Eastern Patients. Int. J. Transl. Med. 2026.

  • Clinical Outcomes and Safety Study of CDK4/6 Inhibitors in Hormone-Positive Metastatic Breast Cancer: A Real-World Tertiary Cancer Centre Experience. Indian J Cancer 2025;62:541–7.

  • MMR Deficiency in Colorectal Cancer Patients: Real-World Evidence from a South India Tertiary Hospital. I0HK, November 2024.

  • Clinical Benefit and Safety of Palbociclib in Hormone-Positive Breast Cancer with Visceral Metastasis: Real-World Experience from a Tertiary Cancer Centre. IJMPO, 2024.

  • Molecular Insights from Comprehensive Genomic Profiling Data in Advanced Metastatic Colorectal Cancer in the South Asian Population. Cancer Research, Statistics and Treatment, Volume 7, Issue 2, April 2024.

  • Role of Preoperative CA-125 Levels in Predicting DFS and OS in Epithelial Ovarian Cancer. IJRCOG, Volume 2, 2018.



Research Projects:

  • Principal Investigator – Fecal Microbiome Analysis in Indian Colorectal Cancer Patients: An Exploratory Study (2023–ongoing).

  • Co-Principal Investigator – Phase IV Study on Compliance and IDFS of Ujvira (TDM-1) (2023–ongoing).

  • Co-Investigator – ctDNA and CTC Monitoring in Colorectal Cancer (2023–ongoing).